Medtronic PLC (MDT)

85.67
0.02 0.02
NYSE : Health Care
Prev Close 85.65
Open 85.95
Day Low/High 85.50 / 86.09
52 Wk Low/High 69.35 / 89.72
Volume 4.29M
Avg Volume 4.33M
Exchange NYSE
Shares Outstanding 1.36B
Market Cap 116.40B
EPS 2.90
P/E Ratio 29.64
Div & Yield 1.84 (2.10%)

Latest News

IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces An Investigation Of Medtronic Plc And Advises Investors With Losses To Contact The Firm

IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces An Investigation Of Medtronic Plc And Advises Investors With Losses To Contact The Firm

Lundin Law PC, a shareholder rights firm, announces that it is investigating claims against Medtronic plc ("Medtronic" or the "Company") (NYSE: MDT) concerning possible violations of federal securities laws.

INVESTOR ALERT: Goldberg Law PC Announces An Investigation Of Medtronic Plc

INVESTOR ALERT: Goldberg Law PC Announces An Investigation Of Medtronic Plc

Goldberg Law PC, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medtronic plc ("Medtronic" or the "Company") (NYSE: MDT).

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors Of An Investigation Involving Possible Securities Fraud Violations By The Board Of Directors Of Medtronic Plc

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors Of An Investigation Involving Possible Securities Fraud Violations By The Board Of Directors Of Medtronic Plc

Levi & Korsinsky announces it has commenced an investigation of Medtronic plc ("Medtronic" or the "Company") (NYSE:MDT) concerning possible violations of federal securities laws.

Glancy Prongay & Murray LLP Commences Investigation On Behalf Of Medtronic Plc Investors

Glancy Prongay & Murray LLP Commences Investigation On Behalf Of Medtronic Plc Investors

Glancy Prongay & Murray LLP ("GPM") announces an investigation on behalf of Medtronic plc ("Medtronic" or the "Company") (NYSE: MDT) investors concerning the Company and its officers' possible violations of...

Medtronic CFO Expects Q1 Sales at Low End of Guidance

Medtronic CFO Expects Q1 Sales at Low End of Guidance

Medtronic is still working to fill back orders.

As Treasury Moves to Bring Back Inversions, Here are 7 of the Biggest Recent Deals

As Treasury Moves to Bring Back Inversions, Here are 7 of the Biggest Recent Deals

The Trump administration's creep towards scrapping certain tax regulations could revive inversion deals that have allowed U.S. companies to avoid billions of dollars in taxes.

Integra's Massive Run-Up Expected to Continue as J&J's Surgical Business Joins the Fold

Integra's Massive Run-Up Expected to Continue as J&J's Surgical Business Joins the Fold

Integra announced in February its intent to acquire Codman Neurosurgery from Johnson & Johnson.

IBM's Security Tie-Up With Cisco Once More Shows Big Blue's Value as a Tech Partner

IBM's Security Tie-Up With Cisco Once More Shows Big Blue's Value as a Tech Partner

Though IBM continues to face major revenue headwinds, its software and services expertise in numerous fields makes it a valuable ally to tech giants and others.

5 Things You Must Know Before the Market Opens Thursday

5 Things You Must Know Before the Market Opens Thursday

U.S. stock futures rise Thursday but European shares fluctuate after global oil prices turn sharply lower.

Market Recon: Oil Prices and the Fed Are the Market's Guides Today

Market Recon: Oil Prices and the Fed Are the Market's Guides Today

U.S. oil producers are becoming more important in any calculation about oil prices.

Week Ahead: With Trump Out of Washington, the Focus Returns to Fed Forecasts

Week Ahead: With Trump Out of Washington, the Focus Returns to Fed Forecasts

Prepare for a week of Fedspeak as members prime markets for a potential interest rate hike in June.

Bulls Won the Day: Cramer's 'Mad Money' Recap (Friday 5/19/17)

Bulls Won the Day: Cramer's 'Mad Money' Recap (Friday 5/19/17)

Ahead of Fed's June meeting, investors will need to start paying close attention to Fed officials and economic data.

Markets Down? Get Used to It: Cramer's 'Mad Money' Recap (Wednesday 5/17/17)

Markets Down? Get Used to It: Cramer's 'Mad Money' Recap (Wednesday 5/17/17)

First serious down day in ages? Jim Cramer says it's as normal as rain; and he has an umbrella for you.

Medtronic Stock Falls Following 'Neutral' Goldman Sachs Initiation

Medtronic Stock Falls Following 'Neutral' Goldman Sachs Initiation

The firm gave the company an $87 price target.

3 Health Care Stocks to Own for 2017

3 Health Care Stocks to Own for 2017

Medtronic, J&J and Cardinal Health appear poised to benefit from an aging U.S. population, say investment experts.

Cramer: These Sectors Look Bullish (Part III)

Cramer: These Sectors Look Bullish (Part III)

From Abbott Labs to Wynn, these names rate checking out.

Cramer: There Are Powerful Themes in Several Bull Markets

Cramer: There Are Powerful Themes in Several Bull Markets

It's a wonder to me how split this market really is.

The Market Is Ready to Change the Pattern

Consider how paltry the number of stocks making new highs has been.

Hit by Generic Deflation, Cardinal Health Expects Pricing to Stabilize Through 2017

Hit by Generic Deflation, Cardinal Health Expects Pricing to Stabilize Through 2017

The Cordis and Medtronic acquisitions are meant to shield Cardinal from the pricing swings of drug distribution.

Cardinal Reports A Healthy Third Quarter

Cardinal Reports A Healthy Third Quarter

Cardinal Health had reported that it expects full year adjusted earnings on the lower end of its guidance.

Good Medicine Makes for 3 Good Charts

Good Medicine Makes for 3 Good Charts

Medtronic, Abbott Labs and Becton Dickinson appear to be offering buying opportunities.

It's the Earnings, Not the Politics: Cramer's 'Mad Money' Recap (Tuesday 4/25/17)

It's the Earnings, Not the Politics: Cramer's 'Mad Money' Recap (Tuesday 4/25/17)

Jim Cramer maintains this rally is fueled by the strong performance of U.S. companies, but says it's worth assessing stock market valuations.